Skip to content

Author

S. T. Wahyudi

We have 3 of 93 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Potential Active Compounds from Cashew (Anacardium occidentale L.) Leaves against SARS-CoV-2 RNA-Dependent RNA Polymerase: An In Silico Study

Five polyphenolic compounds formed stable interactions with RdRp, as indicated by RMSD, RMSF, interaction energy, and radius of gyration analyses, and warrant further in vitro and in vivo evaluation as candidate SARS-CoV-2 RdRp inhibitors.

Willy Wijayanti, N. Yuliana, Endang Prangdimurti et al. · 0 citations
Open access Jul 2026

Molecular Docking and Virtual Screening of Natural Compounds as Potential Anti-Glioblastoma Drugs

Pyranoamentoflavone compounds found in nyamplung, 5,3',5'-Trihydroxy-6,7,4'-trimethoxyflavone in kemuning, and Sotetsuflavone in jamb antidote have good potential as an FGF2 inhibitor as an anti-cancer drug for Glioblastoma.

N. Fernando, Agus Kartono, S. T. Wahyudi · 0 citations
Open access Jul 2026

Exploration of Natural Anti-Hepatocellular Carcinoma Compounds Targeting XIAP-BIR3 Using Molecular Docking, Conventional, and PaCS Molecular Dynamics

Mangostanol and 9-hydroxycalabaxanthone will be prioritized for in vitro/in vivo testing, underscoring the importance of a stepwise, structure-based approach to identify plant-based natural compounds targeting XIAP-BIR3.

S. Hodijah, Agus Kartono, Zahra Silmi Muscifah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.